lipoxin a4 and bay x 1005

lipoxin a4 has been researched along with bay x 1005 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cirino, G; Distrutti, E; Fiorucci, S; Laufor, SA; Mencarelli, A; Morelli, A; Wallace, JL1
Arroyo, V; Clària, J; Gaya, J; González-Périz, A; López-Parra, M; Miquel, R; Planagumà, A; Rodés, J; Titos, E1

Other Studies

2 other study(ies) available for lipoxin a4 and bay x 1005

ArticleYear
Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
    British journal of pharmacology, 2003, Volume: 139, Issue:7

    Topics: Acetates; Acetylation; Adhesiveness; Arachidonate 5-Lipoxygenase; Aspirin; CD11a Antigen; Cells, Cultured; Cyclooxygenase 2; Dose-Response Relationship, Drug; E-Selectin; Eicosanoids; Endothelial Cells; Endothelium, Vascular; Fatty Alcohols; Glycols; Humans; Isoenzymes; Leukocytes; Leukotriene B4; Lipopolysaccharides; Lipoxins; Lipoxygenase; Membrane Proteins; Neutrophils; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Pyrans; Pyrroles; Quinolines; Quinolones; Umbilical Cord; Up-Regulation

2003
Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
    Journal of leukocyte biology, 2005, Volume: 78, Issue:4

    Topics: 5-Lipoxygenase-Activating Proteins; Animals; Arachidonate 5-Lipoxygenase; Carbon Tetrachloride; Carrier Proteins; Cell Count; Chemical and Drug Induced Liver Injury; Chronic Disease; Disease Models, Animal; Hepatocytes; Kupffer Cells; Leukotrienes; Lipoxins; Lipoxygenase Inhibitors; Liver; Liver Diseases; Male; Matrix Metalloproteinase 2; Membrane Proteins; Quinolines; Rats; Rats, Wistar; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2

2005